The JV company will develop a solution for preservative-free glaucoma, dry eye and lid hygiene management, while they will provide total practice solutions for professionals in Canada.
The US-based implantable systems developer plans to use the funds to carry out the global SOLVE-CRT study.
Fluxion is a developer of analytical instruments for cellular analysis, whereas Harvard Bioscience is a specialised products manufacturer.
Both the companies involved in the transaction are based in the US.
genedrive will be responsible for product development and manufacturing, while Sysmex Asia Pacific will be responsible for sales and marketing activities in the Asia-Pacific region.
genedrive is a UK-based molecular diagnostics company, while Sysmex Asia Pacific is a Singapore-based laboratory testing instruments developer.
US-based precision medicine solutions developer Syapse Inc has secured $30m in a Series D venture financing round.
The company plans to use the funds to expand its business operations.